AMGN logo

AMGN Amgen Inc.

NASDAQ Global Select · Drug Manufacturers - General · Healthcare

$443.89
-14.04 (-3.07%)

Amgen Inc., established in 1980 and headquartered in Thousand Oaks, California, is a global biotechnology leader focused on discovering, developing, manufacturing, and delivering groundbreaking human medicines. The company's scientific endeavors span several critical therapeutic categories, including inflammatory conditions, oncology and hematology, bone health, cardiovascular diseases, nephrology…

Market Cap: $240.11Bwww.amgen.com

Price

$435.64-1.49%
$375.65$409.93$444.20$478.48
Aug 25Nov 20

Social Signal Score

54
5d
60
2 mentions
-4.9%
30d
52
58 mentions
-0.8%
60d
53
91 mentions
+7.3%
90d
52
141 mentions
-1.8%
news: 90 · rss: 41 · marketaux: 9 · 4chan: 1

Analyst Ratings

41 analysts
Buyconsensus
Strong Buy 0Buy 21Hold 17Sell 3Strong Sell 0
Avg price target$426.29-4.0%
Low $230Median $430High $531
Current Consensus

52-week range

$313.85$478.48
Last close
$435.64
Off 52w high
-9.0%
200-day average
$383.40
vs 200-day
+13.6%

Revenue

$10.37B+73.76%
$5.46B$7.10B$8.73B$10.37B
Dec 2016Sep 2026

Analyst Estimates

FY2025
$21.32
$21.07–$22.11
23 analysts
FY2026
$23.57+11% YoY
$23.22–$24.16
19 analysts
FY2027
$25.07+6% YoY
$23.55–$26.59
20 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Robert A. Bradway
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
31,500
Beta
0.42
Country
US
Piotroski score
8 / 9 (Strong)
Altman Z-score
2.51
www.amgen.com